Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.69 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.59 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.59 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.59 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.59 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.59 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.59 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL758335 | 1.00 | CHRM5 (0.69) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL2009972 | 1.00 | CHRM5 (0.69) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL28407097 | 0.98 | CHRM5 (0.67) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL5666139 | 0.84 | KDM4E (0.58) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL5666137 | 0.84 | KDM4E (0.58) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL11749513 | 0.82 | CHRM5 (1.00) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL1613845 | 0.78 | CHRM5 (0.69) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL5213059 | 0.78 | CHRM5 (0.69) | CHRM5GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL2164986 | 0.77 | HTT (0.43) | CHRM5MAPTKMT2AMEN1CYP1A2 | |
| SCHEMBL2164984 | 0.77 | HTT (0.43) | CHRM5MAPTKMT2AMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998005630-A1 | PROCESS FOR THE PREPARATION OF ORGANIC NITRILES | ALLIEDSIGNAL INC. (US) | 1998-02-12 | — | — | WO | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| CN-118993933-A | Method for synthesizing m-chlorobenzonitrile from m-chlorotoluene | 江苏聚由新材料科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-113582937-B | Green preparation method of isoxazole compound participated in by water-soluble vitamin E | 浙江工业大学 | 2023-05-23 | — | — | CN | disclosed |
| US-20230135772-A1 | CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-113087722-B | Tricyclic isoxazole compound and preparation method and application thereof | 中国人民解放军海军军医大学 | 2023-04-28 | — | — | CN | disclosed |
| CN-110845486-B | Triazole alcohol derivative and preparation method and application thereof | 中国人民解放军第二军医大学 | 2023-03-21 | — | — | CN | disclosed |
| EP-4130154-A1 | CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT | Asahi Kasei Kabushiki Kaisha (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-115190901-A | Carbodiimide composition, curing agent composition, coating composition, and resin cured product | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-113582937-A | Green preparation method of water-soluble vitamin E-involved isoxazole compound | 浙江工业大学 | 2021-11-02 | — | — | CN | disclosed |
| EP-1114066-A1 | PROCESS FOR THE HYDROGENATION OF A POLYMER COMPOSED OF DIENE MONOMER UNITS AND NITRILE GROUP CONTAINING MONOMER UNITS AND HYDROGENATED POLYMER | DSM N.V. (NL) | 2001-07-11 | — | — | EP | disclosed |
| WO-2001004162-A1 | PROCESS FOR THE HYDROGENATION OF A POLYMER COMPOSED OF DIENE MONOMER UNITS AND A NITRILE GROUP-CONTAINING MONOMER UNITS | DSM N.V. (NL) | 2001-01-18 | — | — | WO | disclosed |
| WO-2000009568-A1 | PROCESS FOR THE HYDROGENATION OF A POLYMER COMPOSED OF DIENE MONOMER UNITS AND NITRILE GROUP CONTAINING MONOMER UNITS AND HYDROGENATED POLYMER | DSM N.V. (NL) | 2000-02-24 | — | — | WO | disclosed |
| WO-1998005630-A1 | PROCESS FOR THE PREPARATION OF ORGANIC NITRILES | ALLIEDSIGNAL INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0427445-B1 | Benzylideneaminoxyalkanoic acid (thio) amide derivative, process for preparing the same and herbicide | UBE INDUSTRIES (JP) | 1994-06-08 | — | — | EP | disclosed |
| EP-0112524-B1 | TRICHLOROACRYLOYL OXIME DERIVATIVES | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-05-28 | — | — | EP | disclosed |
| US-4581365-A | Trichloroacryloyl oxime fungicides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-08 | — | — | US | disclosed |
| EP-0112524-A1 | Trichloroacryloyl oxime derivatives | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-07-04 | — | — | EP | disclosed |
| US-4018645-A | Method of controlling slime during paper manufacture using alpha-chloro-acylbenzaldoxime derivatives | SOMAR MANUFACTURING CO., LTD. (JA) | 1977-04-19 | — | — | US | disclosed |
| US-3968240-A | α-Chloro-o-acylbenzaldoxime derivatives as slime control agents | SOMAR MANUFACTURING CO., LTD. (JA) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | CHRM5 2204/4885GRIN1 846/4885GRIN2B 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.